Quest Diagnostics (DGX) Change in Cash (2009 - 2026)

Quest Diagnostics has reported Change in Cash for 18 years, with the latest figure at $233.0 million in Q2 2026.

• Quarterly Change in Cash rose 77.86% year-over-year to $233.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $307.0 million (up 539.58% YoY) and the FY2025 annual result came in at -$129.0 million, up 5.84% from the prior year.
• Change in Cash improved to $233.0 million in Q2 2026 per DGX's latest filing, from -$27.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $543.0 million in Q4 2023 and troughed at -$385.0 million in Q4 2022.
• A 5-year average of -$13.7 million and a median of -$38.0 million in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2024: Change in Cash tumbled 322.22% in 2022, then soared 2800.0% in 2024.
• Over 5 years, Change in Cash stood at -$385.0 million in 2022, then jumped by 241.04% to $543.0 million in 2023, then tumbled by 139.59% to -$215.0 million in 2024, then soared by 94.42% to -$12.0 million in 2025, then soared by 2041.67% to $233.0 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $233.0 million, -$27.0 million, and -$12.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.